Clark Eliana
Insider CIK 1914448 · NTLA EVP, Chief Technical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NTLA Intellia Therapeutics, Inc | S Sale | 2026-03-02 | 2026-03-03 | 607 | $13.78 | $8.4K | 93,864 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2026-03-01 | 2026-03-03 | 10,505 | — | $0 | 10,505 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award | 2026-03-01 | 2026-03-03 | 7,353 | — | $0 | 94,471 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2026-01-05 | 2026-01-07 | 9,515 | $9.21 | $87.6K | 87,118 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2025-07-01 | 2025-07-03 | 1,022 | $9.82 | $10.0K | 95,369 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2025-03-04 | 2025-03-04 | 679 | $8.99 | $6.1K | 95,369 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2025-03-01 | 2025-03-04 | 45,714 | — | $0 | 45,714 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award | 2025-03-01 | 2025-03-04 | 32,000 | — | $0 | 96,048 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2025-01-03 | 2025-01-06 | 7,422 | $12.18 | $90.4K | 64,048 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2025-01-02 | 2025-01-06 | 556 | $12.03 | $6.7K | 71,470 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2024-07-01 | 2024-07-03 | 405 | $22.93 | $9.3K | 71,470 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2024-03-04 | 2024-03-05 | 605 | $32.99 | $20.0K | 71,470 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2024-03-01 | 2024-03-05 | 45,072 | — | $0 | 45,072 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award | 2024-03-01 | 2024-03-05 | 31,230 | — | $0 | 72,075 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2024-01-03 | 2024-01-05 | 4,301 | $29.46 | $126.7K | 40,845 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2024-01-03 | 2024-01-05 | 307 | $30.12 | $9.2K | 45,146 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2023-07-03 | 2023-07-06 | 360 | $40.51 | $14.6K | 45,146 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | M Exercise deriv | 2023-06-20 | 2023-06-22 | 5,000 | — | $0 | 57,750 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2023-06-20 | 2023-06-22 | 5,000 | $45.00 | $225.0K | 45,146 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | M Exercise | 2023-06-20 | 2023-06-22 | 5,000 | $12.27 | $61.4K | 50,146 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2023-03-01 | 2023-03-03 | 34,674 | — | $0 | 34,674 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award | 2023-03-01 | 2023-03-03 | 24,539 | — | $0 | 39,012 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award | 2023-03-01 | 2023-03-03 | 6,134 | — | $0 | 45,146 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2023-01-04 | 2023-01-06 | 1,692 | $37.21 | $63.0K | 14,473 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2023-01-03 | 2023-01-06 | 231 | $34.48 | $8.0K | 16,165 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2022-07-01 | 2023-01-06 | 105 | $51.74 | $5.4K | 16,165 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award deriv | 2022-03-01 | 2022-03-07 | 15,395 | — | $0 | 15,395 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | A Award | 2022-03-01 | 2022-03-07 | 10,527 | — | $0 | 16,165 | SEC↗ |